medigraphic.com

2023, Number 3

<< Back Next >>

Rev Mex Anest 2023; 46 (3)

Rational management of the diabetic neuropathies: a multidisciplinary expert group consensus

Guillén-Núñez MR, Araujo-Navarrete ME, Duarte-Vega M, Fonseca-Soliz DI, Hernández-Porras BC, Lara-Solares A, Loyo-Galindo A, Negrete-Corona J, Madrigal-Rentería K, Sánchez-Mijangos JH

Language: Spanish
References: 30
Page: 184-190
PDF size: 297.44 Kb.


ABSTRACT

Diabetes mellitus, a chronic and progressive condition, was the third most common cause of death in Mexico between January and June 2021. Its most frequent chronic complication is diabetic neuropathy, which has a major impact on the nervous system. A multidisciplinary group of experts met in Mexico City to establish a treatment algorithm considering the symptomatic and etiopathogenic aspects of diabetic neuropathy. A real-time Delphi method with two rounds of interative questions was used. The implementation of the proposed algorithm will allow a comprehensive approach to the diabetic patient with painful and non-painful neuropathy, both in terms of symptoms and etiopathogenesis. This approach provides the opportunity to improve quality of life and achieve reintegration into family and work life. The expert panel recommends thioctic acid as the first line etiopathogenic treatment for diabetic neuropathy.


REFERENCES

  1. Instituto Nacional de Estadística Geografía e Informática (INEGI). Comunicado de prensa No. 24/22 Estadística de defunciones registradas de enero a junio de 2021 (preliminar). [22 de enero de 2022].

  2. Secretaría de Salud. Norma Oficial Mexicana NOM-015-SSA1-2010, Para la prevención, tratamiento y control de la diabetes mellitus.

  3. Instituto Nacional de Estadística Geografía e Informática (2018). Encuesta Nacional de Salud y Nutrición. Presentación de resultados. [Accesado el 10/oct/22]. Disponible en: https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ensanut_2018_presentacion_resultados.pdf

  4. Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 2017;40:136-154. [Available in: 30 November 2022] Available in: https://diabetesjournals.org/care/article/40/1/136/37160/Diabetic-Neuropathy-A-Position-Statement-by-the

  5. Sampler D, Monerris MM, Homs M, Soler M. Etiología y manejo de la neuropatía diabética dolorosa. Rev Soc Esp Dolor. 2010;17:286-296. [Accesado el 30/nov/2022] Disponible en: https://doi.org/10.1016/j.resed.2010.06.002

  6. Moreira OJ, Castelo C, Boiteux E. Diabetic neuropathy. Rev Dor Sao Paulo. 2016;17:S46-51. [Available in 30 November 2022] Available in: https://www.scielo.br/j/rdor/a/dfMvHLrCg5zrC5J5FjWDKwF/abstract/?lang=pt

  7. Varela-Ruiz M, Díaz-Bravo M, García-Durán R. Descripción y usos del método Delphi en investigaciones del área de la salud. Inv Ed Med 2012;1:90-95. [Accesado el 30/nov/2022] Disponible en: https://www.redalyc.org/pdf/3497/349736303007.pdf

  8. Webler T, Levine D, Rakel H, Renn O. A novel approach to reducing uncertainty: the group Delphi. Tech Forecasting Social Change 1991;39:253-263. [Accessed 30 November 2022] Available in: https://doi.org/10.1016/0040-1625(91)90040-M

  9. Gnatzy T, Warth J, von der Gracht H, Darkow IL. Validating an innovative real-time Delphi approach - A methodological comparison between real-time and conventional Delphi studies. Tech Forecasting Social Change 2011;78:1681-1694. (Accessed 30 November 2022) Available in: https://www.sciencedirect.com/science/article/abs/pii/S0040162511000813?via%3Dihub

  10. International Association for de Study of Pain. IASP Revises Its Definition of Pain for the First Time Since 1979. [Accessed 25 August 2022] Available in: https://www.iasp-pain.org/wp-content/uploads/2022/04/revised-definition-flysheet_R2.pdf

  11. Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice ASC, Treede RD. A new definition of neuropathic pain. Pain. 2018;152:2204-2205. [Accessed 30 November 2022] Available in: https://doi.org/10.1016/j.pain.2011.06.017

  12. Dolor agudo, crónico e intercurrente- American Cancer Society. [Internet] [Accesado el 15 Agosto 2022] Disponible en: https://www.cancer.org/content/dam/CRC/PDF/Public/9394.00.pdf

  13. García-Andreu J. Manejo básico del dolor agudo y crónico. Anestesia en México 2017;29:77-85. [Accesado el 30/nov/2022] Disponible en: https://www.scielo.org.mx/pdf/am/v29s1/2448-8771-am-29-00077.pdf

  14. Nijs J, Lahousse A, Kapreli E, Bilika P, Sarcoglu I, Malfliet A, et al. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J Clin Med 2021;10:3203. [Accessed 30 November 2022] Available in: https://doi.org/10.3390/jcm10153203

  15. Puebla F. Tipos de dolor y Escala terapéutica de O.M.S. Dolor iatrogénico. Oncología 2005;28(3):139-143. [Accesado el 30/nov/2022] Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352005000300006

  16. Ballesteros A. Prevalencia de Neuropatía Somática Sensitiva Distal en pacientes con Diabetes Mellitus tipo 2 de la Unidad de Medicina Familiar No. 28 del IMSS de Mexicali B.C. durante Junio 2013 a Junio 2014. [Accesado el 30/nov/2022] Disponible en: https://repositorioinstitucional.uabc.mx/bitstream/20.500.12930/4508/1/MED014228.pdf

  17. Schreiber A, Nones C, Reis R, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes 2015;6:432-444. [Accessed 30 November 2022] Available in: https://www.wjgnet.com/1948-9358/full/v6/i3/432.htm

  18. American Diabetes Association (ADA); Professional Practice Committee: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S185-184. [Accessed 30 November 2022] Available in: https://doi.org/10.2337/dc22-S01

  19. Botas M, Cervell D, Rodríguez AI Actualización en el diagnóstico, tratamiento y prevención de la neuropatía diabética periférica. Angiología 2017;68:174-181. (Accesado el 30/nov/2022) Disponible en: http://dx.doi.org/10.1016/j.angio.2016.06.005

  20. Marchevsky E, Guaycochea S, Bandersky M et al. Fenotipos y diagnóstico en dolor neuropático. Multidisciplinary Pain Journal 2021. doi: 10.20986/mpj.2021.1008/2021 [Accesado el 30/sep/2022] Disponible en: https://www.mpainjournal.com/fenotipos-y-diagnostico-en-dolor-neuropatico90

  21. Yamazaki D, Hitomi H, Nishiyama A. Hypertension with diabetes mellitus complications. Hypertens Res. 2018;41:147-156. [Accessed 30 November 2022] Available in: https://doi.org/10.1038/s41440-017-0008-y

  22. Ponirakis G, Petropoulus I, Alam U, Ferdousi M, Asghar O, Marshall A, et al. Hypertension contributes to neuropathy in patients with type 1 diabetes. Am J Hypertens. 2019;32:796-803. [Accesado el 30/nov/2022] Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636691/

  23. Fieldmand EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett D, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. [Accessed 30 November 2022] Available in: https://www.nature.com/articles/s41572-019-0092-1

  24. Rosenberg D, Blechschmidt V, Timmerman H, Wolff A, Treede RD. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm (Vienna). 2020;127:589-624. [Accessed 30 November 2022] Disponible en: https://doi.org/10.1007/s00702-020-02145-7

  25. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589. doi: 10.1056/NEJMoa0806470.

  26. Alam U, Arul-Devah V, Javed, Malik RA. Vitamin D and diabetic complications: true or false prophet? Diabetes Ther. 2016;7:11-26. [Accessed 30 November 2022] Available in: https://link.springer.com/article/10.1007/s13300-016-0159-x

  27. Didangelos T, Karlafti E, Kotzakiolafi E, Margariti E, Fiannoulaki P, Batanis G, Tesfaye S, et al. Vitamin B12 supplementation in diabetic neuropathy: a 12 year, randomized, double blind, placebo-controlled trial. Nutrients. 2012;13:395. [Accessed 30 November 2022] Available in: https://doi.org/10.3390/nu13020395

  28. Julian T, Syeed R, Glscow N, Angelopoulou E, Zis P. B12 as a treatment for peripheral neuropathic pain: a systematic. Rev Nutriens. 2020;12:2221. [Accessed 30 November 2022] Available in: https://www.mdpi.com/2072-6643/12/8/2221

  29. Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2012;2012:456279. doi: 10.1155/2012/456279.

  30. Salehi B, Berkay Y, Antika G, Boyunegmez T, Fawzi M, Lobine D, et al. Insights on the use of a-lipoic acid for therapeutic purposes. Biomolecules 2019;9,356. [Accessed 30 November 2022] Disponible en: https://www.mdpi.com/2218-273X/9/8/356




2020     |     www.medigraphic.com